您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (3): 98-102.doi: 10.6040/j.issn.1671-7554.0.2020.1440

• 临床医学 • 上一篇    下一篇

血浆D-二聚体与109例膀胱癌中发生31例转移的关联性分析

高金梅1,张向莲2,刘铁菊3   

  1. 1.天津医科大学第二医院检验科, 天津 300211;2. 天津医科大学第二医院病理科, 天津 300211;3. 天津医科大学基础医学院病理教研室, 天津 300070
  • 发布日期:2021-04-06
  • 通讯作者: 刘铁菊. E-mail:liutieju@126.com
  • 基金资助:
    国家自然科学基金面上项目(81672870)

Correlation between plasma D-dimer and metastasis in 109 cases of bladder cancer

GAO Jinmei1, ZHANG Xianglian2, LIU Tieju3   

  1. 1. Department of Laboratory, The Second Hospital of Tianjin Medical University, Tianjin 300211, China;
    2. Department of Pathology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China;
    3. Department of Pathology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
  • Published:2021-04-06

摘要: 目的 探讨血浆D-二聚体与膀胱癌发生转移的相关性。 方法 回顾性分析2018年11月至2020年10月于天津医科大学第二医院泌尿外科住院的膀胱癌患者109例。根据影像学检查及术后病理检查结果是否发现淋巴结和/或远处转移,将患者分为转移组(31例)和非转移组(78例)。收集患者同期血液常规检验结果并比较其差异。采用多因素Logistic回归模型分析膀胱癌转移的独立危险因素,绘制受试者工作(ROC)曲线,评价血浆D-二聚体对膀胱癌转移的诊断效能。 结果 转移组D-二聚体中位水平为1.37 mg/L,非转移组为0.53 mg/L。多因素Logistic回归结果显示,膀胱癌患者血浆D-二聚体水平升高可能是肿瘤转移的独立危险因素[OR(95%CI)为9.542(3.521,25.935),P<0.05]。以D-二聚体为变量对膀胱癌转移诊断效能的ROC曲线下面积为0.857(P<0.05),最大约登指数对应的D-二聚体临界值为1.16mg/L。D-二聚体对膀胱癌转移的诊断灵敏度65%、特异度94%、假阴性35%、假阳性6%。 结论 血浆D-二聚体水平升高可能是膀胱癌转移的独立危险因素。

关键词: D-二聚体, 膀胱肿瘤, 转移, 相关性

Abstract: Objective To explore the correlation between plasma D-dimer and metastasis of bladder cancer. Methods The clinical data of 109 patients with bladder cancer admitted to the Urology Department of The Second Hospital of Tianjin Medical University during Nov. 2018 and Oct. 2020 were respectively analyzed. The patients were divided into metastatic group(n=31)and non-metastatic group(n=78 cases)based on the presence of lymph nodes and/or distant metastasis detected by imaging and pathological examinations. Results of routine blood tests were also collected and analyzed. The independent risk factors of metastasis were analyzed with multivariate Logistic regression model. The diagnostic efficacy of plasma D-dimer of metastasis was evaluated with receiver operating characteristic(ROC)curve. Results The median level of D-dimer was 1.37 mg/L in the metastatic group and 0.53 mg/L in the non-metastatic group. Multivariate Logistic regression showed that elevated plasma D-dimer level might be an independent risk factor of metastasis [OR(95%CI): 9.542(3.521, 25.935), P<0.05]. The area under the ROC curve was 0.857(P<0.05), and the cut-off point of plasma D-dimer under the maximum Youden index was 1.16 mg/L. The sensitivity, specificity, false negative value and false positive value of D-dimer of bladder cancer metastasis were 65%, 94%, 35% and 6%, respectively. Conclusion Elevated plasma D-dimer level may be an independent risk factor of metastasis of bladder cancer.

Key words: D-dimer, Bladder cancer, Metastasis, Correlation

中图分类号: 

  • R737.14
[1] 刘杰, 崔伟, 车梓, 等. 经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效[J]. 山东大学学报(医学版), 2018, 56(7): 81-85. LIU Jie, CUI Wei, CHE Zi, et al. Efficacy of transurethral resection of bladder tumor in the treatment of muscle-invasive bladder cancer [J]. Journal of Shandong University(Health Sciences), 2018, 56(7): 81-85.
[2] Ella G, Christine M, Oliver K, et al. Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer [J ]. Thromb Haemost, 2019,(5): 17. doi: 10.1111/jth.14484.
[3] Rubio-Jurado B, Balderas-Pena LM, Garaia-Luna EE. Obesity, Thrombotic risk, and inflammation in cancer [J]. Adv Clin Chem, 2018, 1(85): 71-89.
[4] Mainwaring AM, Wells H, Banks T, et al. Skeletal muscle metastasis to vastus lateralis from a urothelial carcinoma: a case report and review of its diagnosis and management [J]. Case Rep Urol, 2019, 2019:8923780. doi: 10.1155/2019/8923780.
[5] Hiensch R, Belete H, Rashidfarokhi M, et al. Unusual patterns of thoracic metastasis of urinary bladder carcinoma [J]. Clin Imaging Sci, 2017, 5(7): 23. doi: 10.4103/jcis.JCIS_9_17.
[6] Inanc M, Er O, Karaca H, et al. D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer [J]. JBUON, 2013,18(2): 391-397.
[7] Dirix L, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer [J]. Br J Cancer, 2002, 86(3): 389-395.
[8] Ya M, Akiyama Y, Okuyama T, et al. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer[J]. Jap J Clin Oncol, 2001, 31(8): 388-394.
[9] Kuderer NM, Ortel TL, Francis CW. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival?[J]. Clin Oncol, 2009, 7(27): 4902-4911.
[10] 郑莹莹, 闫卫利. D-二聚体与肿瘤及其血栓形成的研究进展[J]. 医疗装备, 2018, 31(10): 199-200. ZHENG Yingying, YAN Weili. Research progress of D-dimer and tumor and thrombosis [J]. Medical Equipment, 2018, 31(10): 199-200.
[11] Ierodzik M, Karpatkin S. Hypercoagulability preceding cancer. does hypercoagulability awaken dormant tumor cells in the host?[J]. Thromb Haemost, 2005, 5(3): 577-580.
[12] Raphael L, Olivier P. Metastasis: new functional implications of platelets and megakaryocytes [J]. Blood, 2016, 128(1): 24-31.
[13] Schlesinger M. Role of platelets and platelet receptors in cancer metastasis [J]. J Hematol Oncol, 2018,11(1): 125. doi: 10.1186/s13045-018-0669-2.
[14] Schumacher D, Strilic B, Sivaraj KK, et al. Platelet derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor [J]. Cancer Cell, 2013, 24(1): 130-137.
[15] Riedl J, Preusser M, Nazari PMS, et al. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism [J]. Blood, 2017, 129(13): 1831-1839.
[16] Suzuki-Inoue K. Platelets and cancer: pathology and drug targets [J]. Platelets, 2018, 29(8): 771-772.
[17] 解玉卓, 黄伟, 赵涵, 等. 血清CA125、D-二聚体水平与非小细胞肺癌关系研究进展[J].现代肿瘤医学, 2019, 27(7): 1262-1265. XIE Yuzhuo, HUANG Wei, ZHAO Han, et al. Research progression on the relationship between serum CA125 and D-dimer level and non-small cell lung cancer [J]. Journal of Modern Oncology, 2019, 27(7): 1262-1265.
[18] 吴珊, 王冰, 方征, 等. D-二聚体与癌胚抗原和糖链抗原19-9 在胃癌患者肿瘤负荷及疗效评价中的预测价值[J]. 中国临床保健杂志, 2020, 23(2): 220-222. WU Shan, WANG Bing, FANG Zheng, et al. Predictive value of D-dimer, CEA and CA199 in tumor load and therapeutic evaluation of gastric cancer patients [J]. Chinese Journal of Clinical Healthcare, 2020, 23(2): 220-222.
[19] 卜晓敏, 夏亮, 李立文. D-二聚体联合肿瘤标志物在老年肺癌诊断中的价值[J]. 全科医学临床与教育, 2020, 18(5): 397-400. BU Xiaomin, XIA Liang, LI Liwen. Diagnostic value of combined detection of D-dimer and tumor markers in the aged patients with lung cancer [J]. Clinical Education of General Practice, 2020, 18(5): 397-400.
[20] Guo Y, Chen F, Cui W. Usefulness of plasma D-dimer level for monitoring development of distant organ metastasis in colorectal cancer patients after curative resection [J]. Cancer Manag Res, 2018, 10: 4203-4216. doi: 10.2147/CMAR.S177274.
[21] Dai H, Zhou H, Sun Y, et al. Ddimer as a potential clinical marker for predicting metastasis and progression in cancer [J]. Biomed Rep, 2018, 9(5): 453-457.
[22] Takiuchi T, Blake EA, Matsuo K, et al. Aspirin use and endometrial cancer risk and survival [J]. Gynecol Oncol, 2018, 148(1): 222-232.
[23] Adrien Grancher, Pierre Michel, Frédéric Di Fiore, et al. Aspirin and colorectal cancer [J]. Bull Cancer, 2018, 105(2): 171-180.
[1] 高中霞,张铭,樊明德,谭晨阳,王梦迪,王超,樊跃飞,丁守銮,王成伟. 伽玛刀治疗81例肺癌脑转移瘤的疗效及预后因素[J]. 山东大学学报 (医学版), 2022, 60(8): 44-49.
[2] 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80.
[3] 赵婷婷,齐亚娜,张颖,袁冰,韩明勇. 小鼠乳腺癌诱导转移前肺组织微环境的改变[J]. 山东大学学报 (医学版), 2022, 60(4): 24-29.
[4] 刘丽雯,马俊,李沛铮,张秀芳,刘艺鸣. 128例帕金森病照料者负担及影响因素[J]. 山东大学学报 (医学版), 2022, 60(4): 45-49.
[5] 钟黎黎,盛莹,郭江虹,阳双健,何宜静. LncRNA-UCA1通过靶向调控miR-182-5p对滋养细胞侵袭与转移的影响[J]. 山东大学学报 (医学版), 2022, 60(3): 76-82.
[6] 王静,刘粉,曾荣,黄思源,许长娟,梁子婷,董亮. 以胸膜病变为特征的IgG4相关性肺疾病1例[J]. 山东大学学报 (医学版), 2022, 60(3): 114-116.
[7] 刘芷瑞,郭文强,黄德章,王志刚. 左房黏液瘤致脑梗死及脑转移1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(10): 82-86.
[8] 张欣华,宋庆旭,张宇,刘宏,程玉峰. 肺转移为首发症状的睾丸胚胎性癌治疗1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(10): 110-112.
[9] 陈丽宇,肖娟,吕仙忠,段宝敏,洪凡真. 影响孕产妇下肢深静脉血栓预后的危险因素分析[J]. 山东大学学报 (医学版), 2021, 59(7): 38-42.
[10] 褚晏,刘端瑞,朱文帅,樊荣,马晓丽,汪运山,郏雁飞. DNA甲基化转移酶在胃癌中的表达及其临床意义[J]. 山东大学学报 (医学版), 2021, 59(7): 1-9.
[11] 柴佳威,朱坤兵,张华伟,崔凤云,王甜甜,田兴松. 1例肝细胞肝癌甲状腺转移罕见病例报道与文献回顾[J]. 山东大学学报 (医学版), 2021, 59(3): 120-124.
[12] 李灿楦,陈洁. 基于生物信息学分析乙酰辅酶A酰基转移酶1在肾透明细胞癌中的表达及作用机制[J]. 山东大学学报 (医学版), 2021, 59(2): 26-33.
[13] 张嘉豪,刘东旭. 70例不同垂直骨面型骨性Ⅱ类错牙合磨牙及基骨横向特征[J]. 山东大学学报 (医学版), 2021, 59(2): 76-82.
[14] 郭田,付依林,高聆,宋勇峰,付国斌,耿冲,王潍博. 142例女性乳腺癌患者临床特征与甲状腺激素水平的关联分析[J]. 山东大学学报 (医学版), 2020, 58(6): 53-59.
[15] 杨秀婷,刘启功,左萍,刘正湘,左后娟. CD151-MUT突变对肺腺癌细胞A549迁移的影响及机制[J]. 山东大学学报 (医学版), 2020, 58(3): 81-86.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47 -52 .
[2] 黄飞,王怀经,邢毅,高薇,李永刚,邢子英,李振中. NGF和GM1联合应用对坐骨神经损伤大鼠初级传入神经元的保护作用[J]. 山东大学学报(医学版), 2006, 44(4): 332 -335 .
[3] 李洧,李道卫,叶茜,高顺翠,姜淑娟. 经支气管镜针吸活检在纵隔疾病诊断中的价值[J]. 山东大学学报(医学版), 2008, 46(11): 1063 -1065 .
[4] 吕龙飞,李林,李树海,亓磊,鲁铭,程传乐,田辉. 腔镜下细针导管空肠造瘘在微创McKeown食管癌切除术中的应用[J]. 山东大学学报 (医学版), 2020, 1(7): 77 -81 .
[5] 邵海港, 王璇, 王青. 山东地区人下颌第一前磨牙根管系统解剖研究[J]. 山东大学学报(医学版), 2014, 52(9): 85 -89 .
[6] 唐芳1,2 ,张颖倩3 ,王志强4 ,康殿民4 ,王洁贞1 ,薛付忠1 . 自然疫源性疾病疫源地空间结构的二维
最小生成树模型及其应用
[J]. 山东大学学报(医学版), 2009, 47(01): 106 -110 .
[7] 姜保东,马祥兴,王青,王茜,冯晓源,李克,于富华 . 脑CT静脉造影扫描时相及重建层厚的选择[J]. 山东大学学报(医学版), 2008, 46(11): 1084 -1086 .
[8] 王旭平,赵玲,冯玉新,商林珊,刘金成,曹伟朋,朱晓音,辛华. 绞股蓝总苷对谷氨酸诱导的胎鼠大脑皮层神经元氧化性损伤保护机制的研究[J]. 山东大学学报(医学版), 2006, 44(6): 564 -567 .
[9] 王学萍,杨洪玲. 洛汀新治疗高血压50例报告[J]. 山东大学学报(医学版), 2007, (2): 213 .
[10] 朱晓丽1,郭淑玲1,苏磊1,冯玉新2,袁方曙1. 蠕形螨全蛋白提取及相对分子量鉴定[J]. 山东大学学报(医学版), 2014, 52(5): 58 -62 .